Ultrasound liver imaging for fatty liver disease
Part of Digestive system clinical trials.
This study tests a new ultrasound method to classify fatty liver disease, which might offer a safer and cheaper alternative to MRI. It compares ultrasound results with MRI in healthy people and those with liver disease to see if it can accurately measure liver fat and scarring.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 19 and 75 years old.
- You are either a healthy volunteer with no known liver disease, or you have chronic liver disease (any stage of fibrosis).
- You can speak and read English.
- You are able to have an MRI scan (no metal implants, pacemakers, or other MRI safety concerns).
- You do not have any condition that would make an MRI unsafe for you.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing whether an MRI can help doctors see liver scarring (fibrosis) in people with MASLD, a type of fatty liver disease. It is for patients who already need a liver biopsy as part of their care, to compare the MRI results with the biopsy.
This study is gathering information from people who have had an abdominal ultrasound during a health check-up to learn more about fatty liver disease and how it develops.
This study is testing a new ultrasound method to measure fat in the liver. It is for people who may have a liver condition or have risk factors like diabetes or obesity, as well as healthy volunteers.
This study compares an ultrasound technique with MRI to measure fat in the liver. It aims to see if ultrasound can reliably measure liver fat without needing an MRI, which may be faster and more comfortable for patients with fatty liver disease.
This study tests a new ultrasound device that uses sound waves to measure fat in the liver without needles or surgery. It is for people with a type of fatty liver disease called MASLD or MASH, who are already getting an MRI to check their liver.
This study tests whether a new type of MRI scan can better detect and measure liver disease, including fatty liver and scarring, compared to standard CT scans. If you have chronic liver disease, this study may help improve how we diagnose and track it.
Hear when a new Metabolic Dysfunction-Associated Steatotic Liver Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.